Individualized Antiretroviral Therapy. Impact of pharmacogenetic and therapeutic drug monitoring in the safety and efficacy of first line antirretroviral therapy in patients with HIV infection. Preliminary report
2018 ◽
Vol 73
◽
pp. 243-244
2004 ◽
Vol 26
(5)
◽
pp. 516-523
◽
2001 ◽
Vol 52
(S1)
◽
pp. 89-96
2015 ◽
Vol 48
(2)
◽
pp. S34-S35
Keyword(s):
2018 ◽
Vol 73
◽
pp. 298-299
2004 ◽
Vol 15
(1)
◽
pp. 67-68
◽
2012 ◽
Vol 55
(8)
◽
pp. 1080-1087
◽
Keyword(s):
2003 ◽
Vol 1
(1)
◽
pp. 75-81
◽
Keyword(s):